(Q36895652)

16 August 2017

1 reference

title

Combination antifungal therapy: the new frontier (English)

1 reference

16 August 2017

Jose A Vazquez

1

1 reference

16 August 2017

publication date

1 April 2007

1 reference

16 August 2017

number of pages

25

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

16 August 2017

volume

2

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

115-139

1 reference

The changing face of fungal infections in health care settings

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Echinocandin antifungals: review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combination treatment of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

A Method for Testing for Synergy with Any Number of Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Interactions in vitro between polyenes and imidazoles against yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combined effect of amphotericin B and rifampin on Candida species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Antifungal combinations against Candida albicans biofilms in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Addition of caspofungin to fluconazole does not improve outcome in murine candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Histone acetylation in chromatin structure and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Effects of voriconazole, granulocyte-macrophage colony-stimulating factor, and interferon gamma on intracellular fluconazole-resistant Candida glabrata and Candida krusei in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Human recombinant antibody to HSP90: a natural partner in combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Efficacy of micafungin alone or in combination against systemic murine aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Use of amphotericin B with azole antifungal drugs: what are we doing?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Metabolic studies with 5-fluorocytosine-6-14C in mouse, rat, rabbit, dog and man

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.2.2.115

Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/506617

Identifiers

DOI

10.2217/17460913.2.2.115

1 reference

release_uoncvkjyxjfjnobcpdjnzkutf4

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uoncvkjyxjfjnobcpdjnzkutf4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference